Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
150.2 USD | +1.62% | +0.31% | -21.59% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.59% | 18.69B | |
+50.84% | 63.85B | |
-2.21% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.63% | 26.52B | |
+3.10% | 12.73B | |
+22.07% | 12.11B | |
+27.97% | 12.07B | |
-9.80% | 11.19B |
- Stock Market
- Equities
- ALNY Stock
- News Alnylam Pharmaceuticals, Inc.
- Alnylam Pharmaceuticals' Q1 Non-GAAP Net Loss Narrows as Revenue Increases; 2024 Outlook Affirmed